Cart
sales@molnova.com
Etidocaine Hydrochloride
CAS No. 36637-19-1
Etidocaine Hydrochloride( Duranest | W-19053 | W 19053 | W19053 )
Catalog No. M27981 CAS No. 36637-19-1
Etidocaine Hydrochloride is a long-acting anesthetic and a blocker of the voltage-gated sodium channel.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 264 | Get Quote |
|
| 10MG | 394 | Get Quote |
|
| 25MG | 626 | Get Quote |
|
| 50MG | 885 | Get Quote |
|
| 100MG | 1188 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEtidocaine Hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionEtidocaine Hydrochloride is a long-acting anesthetic and a blocker of the voltage-gated sodium channel.
-
DescriptionEtidocaine Hydrochloride is a long-acting anesthetic and a blocker of the voltage-gated sodium channel.
-
In VitroIGL-EDC formulations can induce a significant increase in human fibroblasts survival. Cell Viability Assay Cell Line:Human fibroblasts cells Concentration:0, 4, 8, 16, 24 mM Incubation Time:4, 6 and 24 h Result:Showed that cell survival decreased in a (EDC) concentration with time-dependent manner.
-
In VivoEtidocaine (spinal injection, 0.0075%, once) does not show postinjection neurologic deficit. Animal Model:Adult Swiss Webster male mice Dosage:0.0075% Administration:Etidocaine(spinal injection, 0.0075%, once)Result:Did not show postinjection neurologic deficit.
-
SynonymsDuranest | W-19053 | W 19053 | W19053
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorD2|5-HT2A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number36637-19-1
-
Formula Weight313.89
-
Molecular FormulaC17H30ClN2O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (199.76 mM)
-
SMILESCl.CCC[NH](CC)C(CC)C(=O)Nc1c(C)cccc1C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yamazaki S, et al. Comparison of prediction methods for in vivo clearance of (S,S)-3-[3-(methylsulfonyl)phenyl]-1-propylpiperidine hydrochloride, a dopamine D2 receptor antagonist, in humans. Drug Metab Dispos. 2004 Apr;32(4):398-404.
molnova catalog
related products
-
Endoxifen HCl
Endoxifen HCl is the active metabolite of Tamoxifen, which is an effective and selective estrogen receptor antagonist.
-
Acecainide
N-Acetylprocainamide is the N-acetylated metabolite of Procainamide, it is a Class III antiarrhythmic agent, whereas procainamide is a Class Ia antiarrhythmic drug.
-
Phrixotoxin 3
Potent blocker of voltage-gated sodium channels (IC50 values are 0.6, 42, and 72 nM for NaV1.2, NaV1.3 and NaV1.5 respectively). Blocks inward sodium currents in a voltage-dependent manner.
